nodes	percent_of_prediction	percent_of_DWPC	metapath
Bezafibrate—CYP1A1—lung cancer	0.327	1	CbGaD
Bezafibrate—CYP1A1—Gefitinib—lung cancer	0.0667	0.185	CbGbCtD
Bezafibrate—SLCO1B1—Irinotecan—lung cancer	0.0485	0.135	CbGbCtD
Bezafibrate—CYP1A1—Erlotinib—lung cancer	0.0394	0.109	CbGbCtD
Bezafibrate—SLCO1B1—Methotrexate—lung cancer	0.0257	0.0713	CbGbCtD
Bezafibrate—CYP2C8—Erlotinib—lung cancer	0.0227	0.0631	CbGbCtD
Bezafibrate—CYP2C8—Paclitaxel—lung cancer	0.0208	0.0578	CbGbCtD
Bezafibrate—CYP3A4—Topotecan—lung cancer	0.0171	0.0473	CbGbCtD
Bezafibrate—CYP2C8—Etoposide—lung cancer	0.0165	0.0456	CbGbCtD
Bezafibrate—CYP3A4—Gefitinib—lung cancer	0.0156	0.0433	CbGbCtD
Bezafibrate—CYP3A4—Teniposide—lung cancer	0.0151	0.042	CbGbCtD
Bezafibrate—CYP3A4—Vinorelbine—lung cancer	0.012	0.0333	CbGbCtD
Bezafibrate—CYP3A4—Crizotinib—lung cancer	0.00956	0.0265	CbGbCtD
Bezafibrate—CYP3A4—Erlotinib—lung cancer	0.00923	0.0256	CbGbCtD
Bezafibrate—CYP3A4—Paclitaxel—lung cancer	0.00845	0.0234	CbGbCtD
Bezafibrate—CYP3A4—Irinotecan—lung cancer	0.00833	0.0231	CbGbCtD
Bezafibrate—CYP3A4—Vinblastine—lung cancer	0.00741	0.0205	CbGbCtD
Bezafibrate—CYP3A4—Etoposide—lung cancer	0.00667	0.0185	CbGbCtD
Bezafibrate—CYP3A4—Docetaxel—lung cancer	0.00611	0.0169	CbGbCtD
Bezafibrate—CYP3A4—Doxorubicin—lung cancer	0.00455	0.0126	CbGbCtD
Bezafibrate—PPARD—mammary gland—lung cancer	0.00404	0.125	CbGeAlD
Bezafibrate—SLCO1B1—mammary gland—lung cancer	0.00219	0.068	CbGeAlD
Bezafibrate—PPARA—epithelium—lung cancer	0.00192	0.0594	CbGeAlD
Bezafibrate—PPARG—mammary gland—lung cancer	0.00189	0.0587	CbGeAlD
Bezafibrate—HMGCR—respiratory system—lung cancer	0.00153	0.0473	CbGeAlD
Bezafibrate—PPARG—Irinotecan—Topotecan—lung cancer	0.00148	0.33	CbGdCrCtD
Bezafibrate—PPARD—lung—lung cancer	0.00143	0.0443	CbGeAlD
Bezafibrate—Clofibrate—GSTA2—lung cancer	0.0014	0.25	CrCbGaD
Bezafibrate—HMGCR—epithelium—lung cancer	0.00128	0.0395	CbGeAlD
Bezafibrate—PPARG—respiratory system—lung cancer	0.00126	0.0391	CbGeAlD
Bezafibrate—HMGCR—bronchus—lung cancer	0.00126	0.0389	CbGeAlD
Bezafibrate—CYP2C8—mammary gland—lung cancer	0.00125	0.0387	CbGeAlD
Bezafibrate—PPARG—Topotecan—Irinotecan—lung cancer	0.00123	0.274	CbGdCrCtD
Bezafibrate—PPARG—Etoposide—Teniposide—lung cancer	0.00122	0.272	CbGdCrCtD
Bezafibrate—PPARA—lung—lung cancer	0.00122	0.0378	CbGeAlD
Bezafibrate—HMGCR—trachea—lung cancer	0.00113	0.035	CbGeAlD
Bezafibrate—HMGCR—cardiac atrium—lung cancer	0.00106	0.0328	CbGeAlD
Bezafibrate—PPARG—epithelium—lung cancer	0.00105	0.0327	CbGeAlD
Bezafibrate—PPARD—lymph node—lung cancer	0.000977	0.0303	CbGeAlD
Bezafibrate—HMGCR—bone marrow—lung cancer	0.000894	0.0277	CbGeAlD
Bezafibrate—PPARA—lymph node—lung cancer	0.000833	0.0258	CbGeAlD
Bezafibrate—HMGCR—lung—lung cancer	0.00081	0.0251	CbGeAlD
Bezafibrate—CYP1A1—respiratory system—lung cancer	0.000767	0.0238	CbGeAlD
Bezafibrate—PPARG—bone marrow—lung cancer	0.000739	0.0229	CbGeAlD
Bezafibrate—PPARG—lung—lung cancer	0.000669	0.0208	CbGeAlD
Bezafibrate—CYP1A1—epithelium—lung cancer	0.000641	0.0199	CbGeAlD
Bezafibrate—CYP1A1—bronchus—lung cancer	0.000631	0.0196	CbGeAlD
Bezafibrate—CYP1A1—trachea—lung cancer	0.000567	0.0176	CbGeAlD
Bezafibrate—PPARG—Teniposide—Etoposide—lung cancer	0.000555	0.124	CbGdCrCtD
Bezafibrate—HMGCR—lymph node—lung cancer	0.000554	0.0172	CbGeAlD
Bezafibrate—CYP1A1—cardiac atrium—lung cancer	0.000533	0.0165	CbGeAlD
Bezafibrate—Clofibrate—CYP2A6—lung cancer	0.000511	0.0916	CrCbGaD
Bezafibrate—Indomethacin—ABCC3—lung cancer	0.000509	0.0912	CrCbGaD
Bezafibrate—Glyburide—ABCC3—lung cancer	0.000459	0.0823	CrCbGaD
Bezafibrate—PPARG—lymph node—lung cancer	0.000458	0.0142	CbGeAlD
Bezafibrate—Indomethacin—UGT1A1—lung cancer	0.00044	0.0788	CrCbGaD
Bezafibrate—Indomethacin—CXCL8—lung cancer	0.000415	0.0743	CrCbGaD
Bezafibrate—CYP1A1—lung—lung cancer	0.000407	0.0126	CbGeAlD
Bezafibrate—Clofibrate—CYP2E1—lung cancer	0.000363	0.065	CrCbGaD
Bezafibrate—Clofibrate—CYP1A1—lung cancer	0.000358	0.0641	CrCbGaD
Bezafibrate—CYP1A1—lymph node—lung cancer	0.000279	0.00864	CbGeAlD
Bezafibrate—Balsalazide—PTGS2—lung cancer	0.000274	0.0492	CrCbGaD
Bezafibrate—Headache—Teniposide—lung cancer	0.000258	0.0018	CcSEcCtD
Bezafibrate—Erythema—Gemcitabine—lung cancer	0.000257	0.00179	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Vinblastine—lung cancer	0.000257	0.00179	CcSEcCtD
Bezafibrate—Thrombocytopenia—Vinorelbine—lung cancer	0.000256	0.00178	CcSEcCtD
Bezafibrate—Muscle spasms—Irinotecan—lung cancer	0.000254	0.00177	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Topotecan—lung cancer	0.00025	0.00174	CcSEcCtD
Bezafibrate—Urinary tract disorder—Etoposide—lung cancer	0.000249	0.00173	CcSEcCtD
Bezafibrate—Photosensitivity—Methotrexate—lung cancer	0.000249	0.00173	CcSEcCtD
Bezafibrate—Pancytopenia—Docetaxel—lung cancer	0.000249	0.00173	CcSEcCtD
Bezafibrate—Abdominal pain—Vinblastine—lung cancer	0.000249	0.00173	CcSEcCtD
Bezafibrate—Urethral disorder—Etoposide—lung cancer	0.000248	0.00172	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Erlotinib—lung cancer	0.000247	0.00172	CcSEcCtD
Bezafibrate—Pharyngitis—Paclitaxel—lung cancer	0.000246	0.00171	CcSEcCtD
Bezafibrate—Nausea—Teniposide—lung cancer	0.000245	0.0017	CcSEcCtD
Bezafibrate—Urinary tract disorder—Paclitaxel—lung cancer	0.000244	0.0017	CcSEcCtD
Bezafibrate—Anaemia—Irinotecan—lung cancer	0.000244	0.0017	CcSEcCtD
Bezafibrate—Alopecia—Cisplatin—lung cancer	0.000244	0.00169	CcSEcCtD
Bezafibrate—Urticaria—Topotecan—lung cancer	0.000243	0.00169	CcSEcCtD
Bezafibrate—Urethral disorder—Paclitaxel—lung cancer	0.000243	0.00169	CcSEcCtD
Bezafibrate—Abdominal pain—Topotecan—lung cancer	0.000242	0.00168	CcSEcCtD
Bezafibrate—Erythema—Cisplatin—lung cancer	0.00024	0.00167	CcSEcCtD
Bezafibrate—Abdominal pain—Erlotinib—lung cancer	0.000239	0.00166	CcSEcCtD
Bezafibrate—Erythema multiforme—Etoposide—lung cancer	0.000239	0.00166	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000238	0.00166	CcSEcCtD
Bezafibrate—Anaemia—Gemcitabine—lung cancer	0.000238	0.00165	CcSEcCtD
Bezafibrate—Renal failure acute—Methotrexate—lung cancer	0.000237	0.00165	CcSEcCtD
Bezafibrate—Flatulence—Cisplatin—lung cancer	0.000236	0.00164	CcSEcCtD
Bezafibrate—Erythema multiforme—Paclitaxel—lung cancer	0.000234	0.00163	CcSEcCtD
Bezafibrate—Hypersensitivity—Vinblastine—lung cancer	0.000232	0.00161	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Docetaxel—lung cancer	0.000232	0.00161	CcSEcCtD
Bezafibrate—Muscle spasms—Cisplatin—lung cancer	0.000231	0.0016	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Docetaxel—lung cancer	0.00023	0.0016	CcSEcCtD
Bezafibrate—Myocardial infarction—Docetaxel—lung cancer	0.000229	0.00159	CcSEcCtD
Bezafibrate—Hypersensitivity—Topotecan—lung cancer	0.000225	0.00157	CcSEcCtD
Bezafibrate—Constipation—Vinorelbine—lung cancer	0.000224	0.00155	CcSEcCtD
Bezafibrate—Pain—Vinorelbine—lung cancer	0.000224	0.00155	CcSEcCtD
Bezafibrate—Glyburide—ABCG2—lung cancer	0.000223	0.04	CrCbGaD
Bezafibrate—Alopecia—Etoposide—lung cancer	0.000223	0.00155	CcSEcCtD
Bezafibrate—Anaemia—Cisplatin—lung cancer	0.000222	0.00154	CcSEcCtD
Bezafibrate—Myalgia—Gemcitabine—lung cancer	0.000219	0.00152	CcSEcCtD
Bezafibrate—Alopecia—Paclitaxel—lung cancer	0.000219	0.00152	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Doxorubicin—lung cancer	0.000218	0.00151	CcSEcCtD
Bezafibrate—Pruritus—Topotecan—lung cancer	0.000216	0.0015	CcSEcCtD
Bezafibrate—Photosensitivity—Doxorubicin—lung cancer	0.000216	0.0015	CcSEcCtD
Bezafibrate—Erythema—Paclitaxel—lung cancer	0.000216	0.0015	CcSEcCtD
Bezafibrate—Diarrhoea—Vinblastine—lung cancer	0.000215	0.0015	CcSEcCtD
Bezafibrate—Infection—Irinotecan—lung cancer	0.000214	0.00149	CcSEcCtD
Bezafibrate—Pruritus—Erlotinib—lung cancer	0.000214	0.00149	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Vinorelbine—lung cancer	0.000214	0.00149	CcSEcCtD
Bezafibrate—Flatulence—Paclitaxel—lung cancer	0.000212	0.00148	CcSEcCtD
Bezafibrate—Vascular purpura—Doxorubicin—lung cancer	0.000212	0.00147	CcSEcCtD
Bezafibrate—Muscle spasms—Etoposide—lung cancer	0.000211	0.00147	CcSEcCtD
Bezafibrate—Thrombocytopenia—Irinotecan—lung cancer	0.000211	0.00147	CcSEcCtD
Bezafibrate—Eczema—Doxorubicin—lung cancer	0.000211	0.00146	CcSEcCtD
Bezafibrate—Diarrhoea—Topotecan—lung cancer	0.000209	0.00145	CcSEcCtD
Bezafibrate—Infection—Gemcitabine—lung cancer	0.000209	0.00145	CcSEcCtD
Bezafibrate—Pharyngitis—Docetaxel—lung cancer	0.000208	0.00145	CcSEcCtD
Bezafibrate—Dizziness—Vinblastine—lung cancer	0.000208	0.00145	CcSEcCtD
Bezafibrate—Urticaria—Vinorelbine—lung cancer	0.000208	0.00144	CcSEcCtD
Bezafibrate—Urinary tract disorder—Docetaxel—lung cancer	0.000207	0.00144	CcSEcCtD
Bezafibrate—Muscle spasms—Paclitaxel—lung cancer	0.000207	0.00144	CcSEcCtD
Bezafibrate—Diarrhoea—Erlotinib—lung cancer	0.000207	0.00144	CcSEcCtD
Bezafibrate—Abdominal pain—Vinorelbine—lung cancer	0.000207	0.00144	CcSEcCtD
Bezafibrate—Urethral disorder—Docetaxel—lung cancer	0.000206	0.00143	CcSEcCtD
Bezafibrate—Thrombocytopenia—Gemcitabine—lung cancer	0.000206	0.00143	CcSEcCtD
Bezafibrate—Renal failure acute—Doxorubicin—lung cancer	0.000205	0.00143	CcSEcCtD
Bezafibrate—Myalgia—Cisplatin—lung cancer	0.000204	0.00142	CcSEcCtD
Bezafibrate—Anaemia—Etoposide—lung cancer	0.000203	0.00141	CcSEcCtD
Bezafibrate—Dizziness—Topotecan—lung cancer	0.000202	0.00141	CcSEcCtD
Bezafibrate—Liver function test abnormal—Methotrexate—lung cancer	0.000202	0.0014	CcSEcCtD
Bezafibrate—Dizziness—Erlotinib—lung cancer	0.0002	0.00139	CcSEcCtD
Bezafibrate—Anaemia—Paclitaxel—lung cancer	0.000199	0.00138	CcSEcCtD
Bezafibrate—Erythema multiforme—Docetaxel—lung cancer	0.000198	0.00138	CcSEcCtD
Bezafibrate—Headache—Vinblastine—lung cancer	0.000197	0.00137	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Methotrexate—lung cancer	0.000197	0.00137	CcSEcCtD
Bezafibrate—Purpura—Doxorubicin—lung cancer	0.000196	0.00137	CcSEcCtD
Bezafibrate—Insomnia—Irinotecan—lung cancer	0.000195	0.00136	CcSEcCtD
Bezafibrate—Infection—Cisplatin—lung cancer	0.000195	0.00135	CcSEcCtD
Bezafibrate—Rash—Topotecan—lung cancer	0.000193	0.00134	CcSEcCtD
Bezafibrate—Hypersensitivity—Vinorelbine—lung cancer	0.000193	0.00134	CcSEcCtD
Bezafibrate—Dermatitis—Topotecan—lung cancer	0.000193	0.00134	CcSEcCtD
Bezafibrate—Thrombocytopenia—Cisplatin—lung cancer	0.000192	0.00133	CcSEcCtD
Bezafibrate—Headache—Topotecan—lung cancer	0.000191	0.00133	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000191	0.00133	CcSEcCtD
Bezafibrate—Rash—Erlotinib—lung cancer	0.000191	0.00133	CcSEcCtD
Bezafibrate—Dermatitis—Erlotinib—lung cancer	0.000191	0.00132	CcSEcCtD
Bezafibrate—Insomnia—Gemcitabine—lung cancer	0.00019	0.00132	CcSEcCtD
Bezafibrate—Dyspepsia—Irinotecan—lung cancer	0.00019	0.00132	CcSEcCtD
Bezafibrate—Headache—Erlotinib—lung cancer	0.000189	0.00132	CcSEcCtD
Bezafibrate—Nausea—Vinblastine—lung cancer	0.000187	0.0013	CcSEcCtD
Bezafibrate—Migraine—Doxorubicin—lung cancer	0.000186	0.0013	CcSEcCtD
Bezafibrate—Alopecia—Docetaxel—lung cancer	0.000185	0.00129	CcSEcCtD
Bezafibrate—Pruritus—Vinorelbine—lung cancer	0.000185	0.00129	CcSEcCtD
Bezafibrate—Pain—Irinotecan—lung cancer	0.000184	0.00128	CcSEcCtD
Bezafibrate—Constipation—Irinotecan—lung cancer	0.000184	0.00128	CcSEcCtD
Bezafibrate—Myalgia—Paclitaxel—lung cancer	0.000183	0.00128	CcSEcCtD
Bezafibrate—Erythema—Docetaxel—lung cancer	0.000183	0.00127	CcSEcCtD
Bezafibrate—Nausea—Topotecan—lung cancer	0.000182	0.00126	CcSEcCtD
Bezafibrate—Constipation—Gemcitabine—lung cancer	0.00018	0.00125	CcSEcCtD
Bezafibrate—Pain—Gemcitabine—lung cancer	0.00018	0.00125	CcSEcCtD
Bezafibrate—Nausea—Erlotinib—lung cancer	0.00018	0.00125	CcSEcCtD
Bezafibrate—Pancytopenia—Methotrexate—lung cancer	0.000179	0.00125	CcSEcCtD
Bezafibrate—Diarrhoea—Vinorelbine—lung cancer	0.000179	0.00124	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000178	0.00124	CcSEcCtD
Bezafibrate—Infection—Etoposide—lung cancer	0.000178	0.00124	CcSEcCtD
Bezafibrate—Blood creatinine increased—Doxorubicin—lung cancer	0.000177	0.00123	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Irinotecan—lung cancer	0.000176	0.00123	CcSEcCtD
Bezafibrate—Thrombocytopenia—Etoposide—lung cancer	0.000176	0.00122	CcSEcCtD
Bezafibrate—Muscle spasms—Docetaxel—lung cancer	0.000176	0.00122	CcSEcCtD
Bezafibrate—Liver function test abnormal—Doxorubicin—lung cancer	0.000175	0.00121	CcSEcCtD
Bezafibrate—Infection—Paclitaxel—lung cancer	0.000175	0.00121	CcSEcCtD
Bezafibrate—Erectile dysfunction—Methotrexate—lung cancer	0.000174	0.00121	CcSEcCtD
Bezafibrate—Dizziness—Vinorelbine—lung cancer	0.000173	0.0012	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Methotrexate—lung cancer	0.000172	0.0012	CcSEcCtD
Bezafibrate—Thrombocytopenia—Paclitaxel—lung cancer	0.000172	0.0012	CcSEcCtD
Bezafibrate—Abdominal pain—Irinotecan—lung cancer	0.00017	0.00119	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.00017	0.00119	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.00017	0.00119	CcSEcCtD
Bezafibrate—Anaemia—Docetaxel—lung cancer	0.000169	0.00117	CcSEcCtD
Bezafibrate—Gastritis—Doxorubicin—lung cancer	0.000168	0.00116	CcSEcCtD
Bezafibrate—Pain—Cisplatin—lung cancer	0.000167	0.00116	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000167	0.00116	CcSEcCtD
Bezafibrate—Muscular weakness—Doxorubicin—lung cancer	0.000167	0.00116	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.000167	0.00116	CcSEcCtD
Bezafibrate—Rash—Vinorelbine—lung cancer	0.000165	0.00115	CcSEcCtD
Bezafibrate—Dermatitis—Vinorelbine—lung cancer	0.000165	0.00115	CcSEcCtD
Bezafibrate—Headache—Vinorelbine—lung cancer	0.000164	0.00114	CcSEcCtD
Bezafibrate—Influenza—Doxorubicin—lung cancer	0.000164	0.00114	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.00016	0.00111	CcSEcCtD
Bezafibrate—Insomnia—Paclitaxel—lung cancer	0.000159	0.00111	CcSEcCtD
Bezafibrate—Hypersensitivity—Irinotecan—lung cancer	0.000159	0.0011	CcSEcCtD
Bezafibrate—Bronchitis—Doxorubicin—lung cancer	0.000157	0.00109	CcSEcCtD
Bezafibrate—Myalgia—Docetaxel—lung cancer	0.000156	0.00108	CcSEcCtD
Bezafibrate—Pancytopenia—Doxorubicin—lung cancer	0.000155	0.00108	CcSEcCtD
Bezafibrate—Nausea—Vinorelbine—lung cancer	0.000155	0.00108	CcSEcCtD
Bezafibrate—Dyspepsia—Paclitaxel—lung cancer	0.000155	0.00108	CcSEcCtD
Bezafibrate—Constipation—Etoposide—lung cancer	0.000153	0.00107	CcSEcCtD
Bezafibrate—Pain—Etoposide—lung cancer	0.000153	0.00107	CcSEcCtD
Bezafibrate—Constipation—Paclitaxel—lung cancer	0.00015	0.00105	CcSEcCtD
Bezafibrate—Pain—Paclitaxel—lung cancer	0.00015	0.00105	CcSEcCtD
Bezafibrate—Pharyngitis—Methotrexate—lung cancer	0.00015	0.00104	CcSEcCtD
Bezafibrate—Urinary tract disorder—Methotrexate—lung cancer	0.000149	0.00104	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Doxorubicin—lung cancer	0.000149	0.00104	CcSEcCtD
Bezafibrate—Pruritus—Gemcitabine—lung cancer	0.000149	0.00103	CcSEcCtD
Bezafibrate—Urethral disorder—Methotrexate—lung cancer	0.000148	0.00103	CcSEcCtD
Bezafibrate—Infection—Docetaxel—lung cancer	0.000148	0.00103	CcSEcCtD
Bezafibrate—Diarrhoea—Irinotecan—lung cancer	0.000148	0.00103	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Etoposide—lung cancer	0.000147	0.00102	CcSEcCtD
Bezafibrate—Thrombocytopenia—Docetaxel—lung cancer	0.000146	0.00101	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000145	0.00101	CcSEcCtD
Bezafibrate—Hypersensitivity—Cisplatin—lung cancer	0.000144	0.001	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Paclitaxel—lung cancer	0.000144	0.001	CcSEcCtD
Bezafibrate—Diarrhoea—Gemcitabine—lung cancer	0.000144	0.000999	CcSEcCtD
Bezafibrate—Erythema multiforme—Methotrexate—lung cancer	0.000143	0.000994	CcSEcCtD
Bezafibrate—Dizziness—Irinotecan—lung cancer	0.000143	0.000991	CcSEcCtD
Bezafibrate—Urticaria—Etoposide—lung cancer	0.000143	0.000991	CcSEcCtD
Bezafibrate—Abdominal pain—Etoposide—lung cancer	0.000142	0.000986	CcSEcCtD
Bezafibrate—Urticaria—Paclitaxel—lung cancer	0.00014	0.000971	CcSEcCtD
Bezafibrate—Abdominal pain—Paclitaxel—lung cancer	0.000139	0.000967	CcSEcCtD
Bezafibrate—Rash—Irinotecan—lung cancer	0.000136	0.000945	CcSEcCtD
Bezafibrate—Dermatitis—Irinotecan—lung cancer	0.000136	0.000944	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000136	0.000944	CcSEcCtD
Bezafibrate—Headache—Irinotecan—lung cancer	0.000135	0.000939	CcSEcCtD
Bezafibrate—Insomnia—Docetaxel—lung cancer	0.000135	0.000937	CcSEcCtD
Bezafibrate—Diarrhoea—Cisplatin—lung cancer	0.000134	0.000931	CcSEcCtD
Bezafibrate—Alopecia—Methotrexate—lung cancer	0.000134	0.000929	CcSEcCtD
Bezafibrate—Rash—Gemcitabine—lung cancer	0.000132	0.000921	CcSEcCtD
Bezafibrate—Dermatitis—Gemcitabine—lung cancer	0.000132	0.00092	CcSEcCtD
Bezafibrate—Hypersensitivity—Etoposide—lung cancer	0.000132	0.000919	CcSEcCtD
Bezafibrate—Erythema—Methotrexate—lung cancer	0.000132	0.000915	CcSEcCtD
Bezafibrate—Headache—Gemcitabine—lung cancer	0.000132	0.000915	CcSEcCtD
Bezafibrate—Dyspepsia—Docetaxel—lung cancer	0.000131	0.000912	CcSEcCtD
Bezafibrate—Pharyngitis—Doxorubicin—lung cancer	0.00013	0.000904	CcSEcCtD
Bezafibrate—Hypersensitivity—Paclitaxel—lung cancer	0.00013	0.000901	CcSEcCtD
Bezafibrate—Urinary tract disorder—Doxorubicin—lung cancer	0.000129	0.000899	CcSEcCtD
Bezafibrate—Urethral disorder—Doxorubicin—lung cancer	0.000128	0.000892	CcSEcCtD
Bezafibrate—Nausea—Irinotecan—lung cancer	0.000128	0.000891	CcSEcCtD
Bezafibrate—Constipation—Docetaxel—lung cancer	0.000127	0.000886	CcSEcCtD
Bezafibrate—Pain—Docetaxel—lung cancer	0.000127	0.000886	CcSEcCtD
Bezafibrate—Pruritus—Etoposide—lung cancer	0.000127	0.000882	CcSEcCtD
Bezafibrate—Nausea—Gemcitabine—lung cancer	0.000125	0.000867	CcSEcCtD
Bezafibrate—Pruritus—Paclitaxel—lung cancer	0.000124	0.000865	CcSEcCtD
Bezafibrate—Erythema multiforme—Doxorubicin—lung cancer	0.000124	0.000861	CcSEcCtD
Bezafibrate—Rash—Cisplatin—lung cancer	0.000123	0.000858	CcSEcCtD
Bezafibrate—Dermatitis—Cisplatin—lung cancer	0.000123	0.000857	CcSEcCtD
Bezafibrate—Diarrhoea—Etoposide—lung cancer	0.000123	0.000853	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Docetaxel—lung cancer	0.000122	0.000847	CcSEcCtD
Bezafibrate—Anaemia—Methotrexate—lung cancer	0.000122	0.000846	CcSEcCtD
Bezafibrate—Indomethacin—PTGS2—lung cancer	0.000121	0.0217	CrCbGaD
Bezafibrate—Diarrhoea—Paclitaxel—lung cancer	0.00012	0.000837	CcSEcCtD
Bezafibrate—Dizziness—Etoposide—lung cancer	0.000119	0.000825	CcSEcCtD
Bezafibrate—Abdominal pain—Docetaxel—lung cancer	0.000118	0.000819	CcSEcCtD
Bezafibrate—Dizziness—Paclitaxel—lung cancer	0.000116	0.000809	CcSEcCtD
Bezafibrate—Nausea—Cisplatin—lung cancer	0.000116	0.000809	CcSEcCtD
Bezafibrate—Alopecia—Doxorubicin—lung cancer	0.000116	0.000804	CcSEcCtD
Bezafibrate—Erythema—Doxorubicin—lung cancer	0.000114	0.000793	CcSEcCtD
Bezafibrate—Rash—Etoposide—lung cancer	0.000113	0.000786	CcSEcCtD
Bezafibrate—Dermatitis—Etoposide—lung cancer	0.000113	0.000786	CcSEcCtD
Bezafibrate—Headache—Etoposide—lung cancer	0.000112	0.000781	CcSEcCtD
Bezafibrate—Flatulence—Doxorubicin—lung cancer	0.000112	0.000781	CcSEcCtD
Bezafibrate—Aminohippurate—ABCB1—lung cancer	0.000112	0.0201	CrCbGaD
Bezafibrate—Myalgia—Methotrexate—lung cancer	0.000112	0.000779	CcSEcCtD
Bezafibrate—Rash—Paclitaxel—lung cancer	0.000111	0.000771	CcSEcCtD
Bezafibrate—Dermatitis—Paclitaxel—lung cancer	0.000111	0.00077	CcSEcCtD
Bezafibrate—Headache—Paclitaxel—lung cancer	0.00011	0.000766	CcSEcCtD
Bezafibrate—Hypersensitivity—Docetaxel—lung cancer	0.00011	0.000764	CcSEcCtD
Bezafibrate—Muscle spasms—Doxorubicin—lung cancer	0.00011	0.000762	CcSEcCtD
Bezafibrate—Indomethacin—ALB—lung cancer	0.000108	0.0193	CrCbGaD
Bezafibrate—Infection—Methotrexate—lung cancer	0.000107	0.000742	CcSEcCtD
Bezafibrate—Nausea—Etoposide—lung cancer	0.000107	0.000741	CcSEcCtD
Bezafibrate—Pruritus—Docetaxel—lung cancer	0.000105	0.000733	CcSEcCtD
Bezafibrate—Anaemia—Doxorubicin—lung cancer	0.000105	0.000733	CcSEcCtD
Bezafibrate—Thrombocytopenia—Methotrexate—lung cancer	0.000105	0.000731	CcSEcCtD
Bezafibrate—Nausea—Paclitaxel—lung cancer	0.000104	0.000726	CcSEcCtD
Bezafibrate—Indomethacin—ABCB1—lung cancer	0.000103	0.0184	CrCbGaD
Bezafibrate—Diarrhoea—Docetaxel—lung cancer	0.000102	0.000709	CcSEcCtD
Bezafibrate—Dizziness—Docetaxel—lung cancer	9.86e-05	0.000685	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Methotrexate—lung cancer	9.79e-05	0.000681	CcSEcCtD
Bezafibrate—Glyburide—ALB—lung cancer	9.73e-05	0.0174	CrCbGaD
Bezafibrate—Insomnia—Methotrexate—lung cancer	9.72e-05	0.000676	CcSEcCtD
Bezafibrate—Myalgia—Doxorubicin—lung cancer	9.71e-05	0.000675	CcSEcCtD
Bezafibrate—Dyspepsia—Methotrexate—lung cancer	9.46e-05	0.000658	CcSEcCtD
Bezafibrate—Rash—Docetaxel—lung cancer	9.4e-05	0.000653	CcSEcCtD
Bezafibrate—Dermatitis—Docetaxel—lung cancer	9.39e-05	0.000653	CcSEcCtD
Bezafibrate—Headache—Docetaxel—lung cancer	9.34e-05	0.000649	CcSEcCtD
Bezafibrate—Glyburide—ABCB1—lung cancer	9.29e-05	0.0166	CrCbGaD
Bezafibrate—Infection—Doxorubicin—lung cancer	9.24e-05	0.000643	CcSEcCtD
Bezafibrate—Pain—Methotrexate—lung cancer	9.19e-05	0.000639	CcSEcCtD
Bezafibrate—Thrombocytopenia—Doxorubicin—lung cancer	9.11e-05	0.000633	CcSEcCtD
Bezafibrate—Nausea—Docetaxel—lung cancer	8.85e-05	0.000616	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Methotrexate—lung cancer	8.79e-05	0.000611	CcSEcCtD
Bezafibrate—Urticaria—Methotrexate—lung cancer	8.54e-05	0.000593	CcSEcCtD
Bezafibrate—Abdominal pain—Methotrexate—lung cancer	8.49e-05	0.00059	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Doxorubicin—lung cancer	8.48e-05	0.000589	CcSEcCtD
Bezafibrate—Insomnia—Doxorubicin—lung cancer	8.41e-05	0.000585	CcSEcCtD
Bezafibrate—Dyspepsia—Doxorubicin—lung cancer	8.19e-05	0.000569	CcSEcCtD
Bezafibrate—Pain—Doxorubicin—lung cancer	7.96e-05	0.000553	CcSEcCtD
Bezafibrate—Constipation—Doxorubicin—lung cancer	7.96e-05	0.000553	CcSEcCtD
Bezafibrate—Hypersensitivity—Methotrexate—lung cancer	7.92e-05	0.00055	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Doxorubicin—lung cancer	7.61e-05	0.000529	CcSEcCtD
Bezafibrate—Pruritus—Methotrexate—lung cancer	7.6e-05	0.000528	CcSEcCtD
Bezafibrate—Urticaria—Doxorubicin—lung cancer	7.39e-05	0.000514	CcSEcCtD
Bezafibrate—Abdominal pain—Doxorubicin—lung cancer	7.35e-05	0.000511	CcSEcCtD
Bezafibrate—Diarrhoea—Methotrexate—lung cancer	7.35e-05	0.000511	CcSEcCtD
Bezafibrate—Dizziness—Methotrexate—lung cancer	7.11e-05	0.000494	CcSEcCtD
Bezafibrate—Hypersensitivity—Doxorubicin—lung cancer	6.85e-05	0.000477	CcSEcCtD
Bezafibrate—Rash—Methotrexate—lung cancer	6.77e-05	0.000471	CcSEcCtD
Bezafibrate—Dermatitis—Methotrexate—lung cancer	6.77e-05	0.000471	CcSEcCtD
Bezafibrate—Headache—Methotrexate—lung cancer	6.73e-05	0.000468	CcSEcCtD
Bezafibrate—Pruritus—Doxorubicin—lung cancer	6.58e-05	0.000458	CcSEcCtD
Bezafibrate—Nausea—Methotrexate—lung cancer	6.38e-05	0.000444	CcSEcCtD
Bezafibrate—Diarrhoea—Doxorubicin—lung cancer	6.37e-05	0.000443	CcSEcCtD
Bezafibrate—Dizziness—Doxorubicin—lung cancer	6.15e-05	0.000428	CcSEcCtD
Bezafibrate—Rash—Doxorubicin—lung cancer	5.87e-05	0.000408	CcSEcCtD
Bezafibrate—Dermatitis—Doxorubicin—lung cancer	5.86e-05	0.000407	CcSEcCtD
Bezafibrate—Headache—Doxorubicin—lung cancer	5.83e-05	0.000405	CcSEcCtD
Bezafibrate—Nausea—Doxorubicin—lung cancer	5.53e-05	0.000384	CcSEcCtD
Bezafibrate—CYP2C8—Metabolism—GSTA3—lung cancer	1.5e-05	0.000119	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—RRM1—lung cancer	1.5e-05	0.000119	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTA4—lung cancer	1.5e-05	0.000119	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CAT—lung cancer	1.48e-05	0.000117	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MAPK3—lung cancer	1.47e-05	0.000117	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.47e-05	0.000116	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—CREBBP—lung cancer	1.47e-05	0.000116	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTA2—lung cancer	1.46e-05	0.000116	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CB—lung cancer	1.46e-05	0.000115	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CYP2E1—lung cancer	1.45e-05	0.000115	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CG—lung cancer	1.45e-05	0.000114	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PTGS2—lung cancer	1.44e-05	0.000114	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ABCB1—lung cancer	1.44e-05	0.000114	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—NQO1—lung cancer	1.43e-05	0.000113	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—B4GALT5—lung cancer	1.41e-05	0.000112	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—TYMS—lung cancer	1.41e-05	0.000112	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTA1—lung cancer	1.41e-05	0.000112	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ATP5H—lung cancer	1.41e-05	0.000111	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.4e-05	0.000111	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—EGFR—lung cancer	1.4e-05	0.000111	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—POMC—lung cancer	1.4e-05	0.000111	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GSTM1—lung cancer	1.4e-05	0.00011	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ABCC3—lung cancer	1.4e-05	0.00011	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.39e-05	0.00011	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CD—lung cancer	1.39e-05	0.00011	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—AKT1—lung cancer	1.39e-05	0.00011	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—MAPK3—lung cancer	1.38e-05	0.000109	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—POMC—lung cancer	1.38e-05	0.000109	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTA4—lung cancer	1.38e-05	0.000109	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—ALB—lung cancer	1.37e-05	0.000108	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—RAF1—lung cancer	1.37e-05	0.000108	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—AKR1C1—lung cancer	1.35e-05	0.000107	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.34e-05	0.000106	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—MYC—lung cancer	1.34e-05	0.000106	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CREBBP—lung cancer	1.34e-05	0.000106	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTA2—lung cancer	1.34e-05	0.000106	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—KRAS—lung cancer	1.33e-05	0.000105	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CYP1A1—lung cancer	1.32e-05	0.000105	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ERCC2—lung cancer	1.31e-05	0.000104	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—UGT1A1—lung cancer	1.31e-05	0.000104	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTA1—lung cancer	1.29e-05	0.000102	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—STK11—lung cancer	1.29e-05	0.000102	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ABCC3—lung cancer	1.28e-05	0.000101	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CD—lung cancer	1.27e-05	0.0001	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GNG11—lung cancer	1.27e-05	0.0001	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.26e-05	9.95e-05	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PTEN—lung cancer	1.26e-05	9.94e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ALB—lung cancer	1.26e-05	9.92e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PLBD1—lung cancer	1.25e-05	9.9e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—AKR1C1—lung cancer	1.24e-05	9.79e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—CREBBP—lung cancer	1.24e-05	9.77e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.21e-05	9.59e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CB—lung cancer	1.21e-05	9.58e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALDOA—lung cancer	1.2e-05	9.52e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—UGT1A1—lung cancer	1.2e-05	9.5e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PTGS2—lung cancer	1.2e-05	9.49e-05	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—EP300—lung cancer	1.2e-05	9.47e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GSTP1—lung cancer	1.2e-05	9.45e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NCOA3—lung cancer	1.17e-05	9.24e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CAT—lung cancer	1.16e-05	9.2e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GNG11—lung cancer	1.16e-05	9.16e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.16e-05	9.15e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.15e-05	9.12e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.15e-05	9.08e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HSD17B10—lung cancer	1.15e-05	9.06e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ABCG2—lung cancer	1.14e-05	8.99e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ADCY1—lung cancer	1.14e-05	8.99e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—APOA1—lung cancer	1.14e-05	8.97e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ABCB1—lung cancer	1.13e-05	8.95e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—HRAS—lung cancer	1.13e-05	8.9e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ENO2—lung cancer	1.12e-05	8.81e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—HPGDS—lung cancer	1.12e-05	8.81e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—TYMS—lung cancer	1.11e-05	8.79e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CB—lung cancer	1.11e-05	8.76e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PPP2R1B—lung cancer	1.11e-05	8.76e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALDOA—lung cancer	1.1e-05	8.73e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GSTM1—lung cancer	1.1e-05	8.69e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PTGS2—lung cancer	1.1e-05	8.68e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.09e-05	8.64e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.09e-05	8.59e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTT1—lung cancer	1.08e-05	8.55e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—IL6—lung cancer	1.08e-05	8.52e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NCOA3—lung cancer	1.07e-05	8.47e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP2A6—lung cancer	1.07e-05	8.45e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GCLC—lung cancer	1.07e-05	8.45e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CKB—lung cancer	1.07e-05	8.42e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.07e-05	8.42e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.05e-05	8.32e-05	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—MAPK3—lung cancer	1.05e-05	8.32e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PTEN—lung cancer	1.05e-05	8.28e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ADCY1—lung cancer	1.04e-05	8.24e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ABCG2—lung cancer	1.04e-05	8.24e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CYP1A1—lung cancer	1.04e-05	8.24e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CG—lung cancer	1.04e-05	8.19e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ERCC2—lung cancer	1.03e-05	8.17e-05	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—MYC—lung cancer	1.02e-05	8.09e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—HPGDS—lung cancer	1.02e-05	8.08e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ENO2—lung cancer	1.02e-05	8.08e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PPP2R1B—lung cancer	1.02e-05	8.03e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ENO1—lung cancer	1.01e-05	8.01e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.01e-05	7.98e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—POMC—lung cancer	1e-05	7.92e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTM2—lung cancer	1e-05	7.92e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CNDP2—lung cancer	1e-05	7.92e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—EP300—lung cancer	9.99e-06	7.89e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—ALB—lung cancer	9.97e-06	7.88e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—AKT1—lung cancer	9.95e-06	7.86e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTT1—lung cancer	9.92e-06	7.84e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—POMC—lung cancer	9.87e-06	7.8e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GCLC—lung cancer	9.81e-06	7.75e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP2A6—lung cancer	9.81e-06	7.75e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	9.77e-06	7.72e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—MTMR3—lung cancer	9.75e-06	7.7e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CREBBP—lung cancer	9.61e-06	7.6e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PTEN—lung cancer	9.58e-06	7.57e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PGAM1—lung cancer	9.5e-06	7.5e-05	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—AKT1—lung cancer	9.32e-06	7.36e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ENO1—lung cancer	9.3e-06	7.34e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	9.26e-06	7.32e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	9.14e-06	7.22e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—EP300—lung cancer	9.14e-06	7.22e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CD—lung cancer	9.12e-06	7.2e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP2E1—lung cancer	9.09e-06	7.19e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP2A7—lung cancer	9.06e-06	7.16e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ALB—lung cancer	9e-06	7.11e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NQO1—lung cancer	8.99e-06	7.1e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—APOA1—lung cancer	8.94e-06	7.07e-05	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CA—lung cancer	8.87e-06	7.01e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SDC4—lung cancer	8.87e-06	7.01e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	8.8e-06	6.96e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	8.72e-06	6.89e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.56e-06	6.77e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP2E1—lung cancer	8.34e-06	6.59e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NQO1—lung cancer	8.24e-06	6.51e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CG—lung cancer	8.16e-06	6.45e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—STK11—lung cancer	8.11e-06	6.4e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTA3—lung cancer	8.08e-06	6.38e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—RRM1—lung cancer	8.08e-06	6.38e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	8.07e-06	6.38e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	8e-06	6.32e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CB—lung cancer	7.94e-06	6.28e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PTGS2—lung cancer	7.87e-06	6.22e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—POMC—lung cancer	7.77e-06	6.14e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	7.61e-06	6.01e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—B4GALT5—lung cancer	7.59e-06	6e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CREBBP—lung cancer	7.57e-06	5.98e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—MAPK3—lung cancer	7.54e-06	5.96e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTP1—lung cancer	7.5e-06	5.93e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—STK11—lung cancer	7.43e-06	5.87e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CA—lung cancer	7.39e-06	5.84e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTA4—lung cancer	7.39e-06	5.84e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—MYC—lung cancer	7.34e-06	5.8e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CAT—lung cancer	7.3e-06	5.77e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.26e-06	5.73e-05	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—AKT1—lung cancer	7.25e-06	5.73e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTA2—lung cancer	7.2e-06	5.69e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CD—lung cancer	7.18e-06	5.67e-05	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—AKT1—lung cancer	7.1e-06	5.61e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ABCB1—lung cancer	7.1e-06	5.61e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ALB—lung cancer	7.09e-06	5.6e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.98e-06	5.51e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—TYMS—lung cancer	6.97e-06	5.51e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTA1—lung cancer	6.94e-06	5.49e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTM1—lung cancer	6.89e-06	5.45e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTP1—lung cancer	6.88e-06	5.43e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ABCC3—lung cancer	6.87e-06	5.43e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PTEN—lung cancer	6.87e-06	5.42e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CA—lung cancer	6.76e-06	5.34e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CAT—lung cancer	6.69e-06	5.29e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.65e-06	5.26e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AKR1C1—lung cancer	6.65e-06	5.25e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—EP300—lung cancer	6.55e-06	5.17e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ABCB1—lung cancer	6.51e-06	5.14e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ERCC2—lung cancer	6.48e-06	5.12e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—UGT1A1—lung cancer	6.46e-06	5.1e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—TYMS—lung cancer	6.39e-06	5.05e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTM1—lung cancer	6.32e-06	4.99e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CB—lung cancer	6.26e-06	4.94e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GNG11—lung cancer	6.23e-06	4.92e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PTGS2—lung cancer	6.2e-06	4.9e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—AKT1—lung cancer	6.04e-06	4.77e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP1A1—lung cancer	5.99e-06	4.73e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ERCC2—lung cancer	5.94e-06	4.69e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALDOA—lung cancer	5.93e-06	4.68e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NCOA3—lung cancer	5.75e-06	4.55e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—APOA1—lung cancer	5.61e-06	4.43e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ABCG2—lung cancer	5.6e-06	4.42e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ADCY1—lung cancer	5.6e-06	4.42e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—AKT1—lung cancer	5.52e-06	4.36e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HPGDS—lung cancer	5.49e-06	4.34e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ENO2—lung cancer	5.49e-06	4.34e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.46e-06	4.31e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PTEN—lung cancer	5.41e-06	4.27e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.37e-06	4.24e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTT1—lung cancer	5.32e-06	4.21e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GCLC—lung cancer	5.26e-06	4.16e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP2A6—lung cancer	5.26e-06	4.16e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—EP300—lung cancer	5.16e-06	4.07e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—APOA1—lung cancer	5.14e-06	4.06e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CG—lung cancer	5.12e-06	4.04e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—AKT1—lung cancer	5.09e-06	4.02e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ENO1—lung cancer	4.99e-06	3.94e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.92e-06	3.89e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—POMC—lung cancer	4.87e-06	3.85e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CA—lung cancer	4.84e-06	3.83e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CREBBP—lung cancer	4.74e-06	3.75e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CG—lung cancer	4.69e-06	3.71e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CD—lung cancer	4.5e-06	3.55e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP2E1—lung cancer	4.47e-06	3.54e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—POMC—lung cancer	4.47e-06	3.53e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALB—lung cancer	4.44e-06	3.51e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NQO1—lung cancer	4.42e-06	3.5e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CREBBP—lung cancer	4.35e-06	3.44e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CD—lung cancer	4.12e-06	3.26e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALB—lung cancer	4.07e-06	3.22e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—STK11—lung cancer	3.99e-06	3.15e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—AKT1—lung cancer	3.96e-06	3.13e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CB—lung cancer	3.92e-06	3.1e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PTGS2—lung cancer	3.89e-06	3.07e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CA—lung cancer	3.81e-06	3.01e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTP1—lung cancer	3.69e-06	2.92e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CB—lung cancer	3.59e-06	2.84e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CAT—lung cancer	3.59e-06	2.84e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PTGS2—lung cancer	3.56e-06	2.81e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ABCB1—lung cancer	3.49e-06	2.76e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—TYMS—lung cancer	3.43e-06	2.71e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTM1—lung cancer	3.39e-06	2.68e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PTEN—lung cancer	3.39e-06	2.68e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—EP300—lung cancer	3.23e-06	2.55e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP1A1—lung cancer	3.22e-06	2.54e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ERCC2—lung cancer	3.19e-06	2.52e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—AKT1—lung cancer	3.12e-06	2.46e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PTEN—lung cancer	3.11e-06	2.45e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—EP300—lung cancer	2.96e-06	2.34e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—APOA1—lung cancer	2.76e-06	2.18e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CG—lung cancer	2.52e-06	1.99e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—POMC—lung cancer	2.4e-06	1.89e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CA—lung cancer	2.39e-06	1.89e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CREBBP—lung cancer	2.33e-06	1.84e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CD—lung cancer	2.21e-06	1.75e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CA—lung cancer	2.19e-06	1.73e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALB—lung cancer	2.19e-06	1.73e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—AKT1—lung cancer	1.95e-06	1.54e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CB—lung cancer	1.93e-06	1.52e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PTGS2—lung cancer	1.91e-06	1.51e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—AKT1—lung cancer	1.79e-06	1.41e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PTEN—lung cancer	1.67e-06	1.32e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—EP300—lung cancer	1.59e-06	1.26e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CA—lung cancer	1.18e-06	9.29e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AKT1—lung cancer	9.61e-07	7.59e-06	CbGpPWpGaD
